Quick Answer
KALA BIO, Inc. reported Long-Term Debt of $20.10 million for fiscal year 2024.
KALA BIO, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2024 | $20.10M | -41.2% |
| 2023 | $34.19M | -9.9% |
| 2022 | $37.94M | -51.9% |
| 2021 | $78.93M | +9.3% |
| 2020 | $72.24M | +1.5% |
| 2019 | $71.18M | +1.4% |
| 2018 | $70.23M | +485.9% |
| 2017 | $11.99M | +31.8% |
| 2016 | $9.10M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $18.79M | -17.7% | +24.2% |
| March 31, 2025 | $15.12M | -47.0% | -24.8% |
| December 31, 2024 | $20.10M | -41.2% | +17.1% |
| September 30, 2024 | $17.16M | -49.3% | -24.8% |
| June 30, 2024 | $22.83M | -32.0% | -19.9% |
| March 31, 2024 | $28.51M | -14.3% | -16.6% |
| December 31, 2023 | $34.19M | -9.9% | +0.9% |
| September 30, 2023 | $33.88M | -20.6% | +0.9% |
- KALA BIO, Inc. showed a decrease of -41.2% in Long-Term Debt compared to the prior fiscal year.
- Over the 2016–2024 period, KALA BIO, Inc.’s long-term debt has grown by 120.9% (from $9.10 million to $20.10 million).
- The most recent figure is from KALA BIO, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: